Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyVentura County CGM Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentVentura County Health Care PlanPolicy 013

    Continuous Glucose Monitoring

    Customize your policy alerts

    Sign up for venturacountyhealthcareplan Policy 013 alerts

    Get alerted when Policy 013 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs authorization and medical-necessity criteria for continuous glucose monitoring equipment and supplies. Contracted DME providers do not require authorization for specified CGM equipment and supplies, while non-contracted DME providers require authorization subject to the stated clinical criteria.

    Policy Summary
    PayerVentura County Health Care Plan
    PolicyContinuous Glucose Monitoring
    Policy CodePolicy 013
    Change TypeRevised
    Effective DateNov 10, 2016
    Last ReviewFeb 12, 2026
    Next Review DateNot specified
    Key ActionObtain authorization when CGM equipment or supplies are furnished by a non-contracted DME provider.
    SourceLink
    POLICY UPDATE CHANGES

    Prior authorization was removed for contracted DME providers furnishing specified CGM equipment and supplies.

    Type 2 diabetes was added as an eligible diabetes diagnosis.

    The policy clarified that the contracted-DME-provider authorization exception applies to the CGM machine and both initial and refill supplies.

    The policy added that the patient is to remain on the appropriate dosage determined by the treating provider.

    2Eligible diabetes types
    8 yearsMinimum age

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3+ daily
    Required finger sticks
    7Qualifying indications
    5CGM billing codes

    Initial CGM Approval Criteria

    Initial CGM Approval for Non-Contracted DME Providers

    VCHCP will approve CGM equipment for a non-contracted DME-provider request when all base criteria are met and at least one qualifying clinical indication is present.

    Base criteria

    • Eligibility and treatment requirements: Type 1 or Type 2 diabetes; age 8 years or older based on assessed capability of being trained to use the device appropriately; FDA-approved device; consultation with an endocrinologist or other diabetes specialist; device ordered through a VCHCP contracted DME vendor; and best practices followed, including 3 or more finger sticks each day, proper diet and exercise, dietary and diabetic counseling, and monitoring.Age >= 8 years; 3 or more finger sticks daily
    • ONE of the following qualifying clinical indications

      • Brittle diabetes: Documented extreme (brittle) diabetes, defined as recurrent fluctuations in blood glucose measurements, including symptomatic glucose levels < 50 mg/dL or > 300 mg/dL.< 50 mg/dL or > 300 mg/dL
      • Refractory poor control: Poorly controlled blood glucose levels with unexplained hypoglycemic episodes or recurrent diabetic ketoacidosis, refractory to multiple adjustments in self-monitoring of blood glucose and insulin administration in compliant patients.
      • Frequent hospitalizations for poorly controlled diabetes.
      • Pregnancy or postpartum indication: Pregnant and incapable of, or poorly compliant in, self-monitoring, including one-month postpartum, or poorly controlled despite best practices.Includes one-month postpartum
      • Hypoglycemic unawareness: Documented and clinically significant hypoglycemic unawareness after dietary, blood glucose, behavioral, and medical-management adjustments, such as carbohydrate absorption inhibitors.
      • Nocturnal hypoglycemia: Frequent nocturnal hypoglycemia despite appropriate modifications in insulin therapy and best practices.
      • Legal blindness: The patient is legally blind and blood glucose levels are poorly controlled despite best practices; a special device is required.
    Treatment-plan requirement: The patient is to remain on the appropriate dosage determined by the treating provider.

    Covered CGM Codes and Thresholds

    Dexcom continuous glucose monitoring codesHCPCS
    A9277Dexcom CGM code listed for the CGM machine or supplies
    A9278Dexcom CGM code listed for the CGM machine or supplies
    A9276Dexcom CGM code listed for the CGM machine or supplies
    Freestyle Libre continuous glucose monitoring codesHCPCS
    K0554Freestyle Libre CGM code listed for the CGM machine or supplies
    K0553Freestyle Libre CGM code listed for the CGM machine or supplies
    Minimum age
    Minimum age8 years or older
    Training capabilityBased on assessed capability of being trained to use the device in an appropriate manner
    Eligibility contextThe age and training-capability requirement applies to continuous glucose monitoring device coverage
    Finger-stick frequency
    Required frequency3 or more finger sticks each day
    Best-practice requirementA regimen of 3 or more finger sticks each day is part of following best practices

    Authorization, Documentation, and Review

    Prior Authorization

    DME Provider Authorization

    Authorization is required for non-contracted DME providers. No authorization is required when a contracted DME provider supplies the continuous glucose monitor and initial or refill supplies, including Dexcom (A9277, A9278, A9276) and FreeStyle Libre (K0554, K0553). VCHCP approval for non-contracted DME requests is subject to the policy criteria.

    • Non-contracted DME providers: prior authorization required.
    • Contracted DME providers: no authorization required for the listed CGM equipment and supplies.
    Documentation Required

    Required Clinical Documentation

    Document all required clinical criteria and supporting records before requesting CGM coverage. The patient must meet all base criteria and have at least one qualifying clinical indication.

    • Type 1 or Type 2 diabetes.

    Continuous Glucose Monitoring Context

    Continuous glucose monitoring (CGM) is intended to supplement, not replace, finger-stick glucose measurements. CGM readings should ideally be crosschecked with a finger-stick measurement before making insulin adjustments, and the device should be used as part of appropriate clinical monitoring and treatment.

    Clinical Terms

    Extreme (brittle) diabetes
    DefinitionRecurrent fluctuations in blood glucose measurements
    Low symptomatic levelSymptomatic glucose levels below 50 mg/dL
    High symptomatic levelSymptomatic glucose levels above 300 mg/dL
    Hypoglycemic unawareness
    DocumentationThe inability to recognize hypoglycemia must be documented
    Clinical significanceThe inability to recognize hypoglycemia must be clinically significant
    Required management history
    Policy Summary
    PayerVentura County Health Care Plan
    PolicyContinuous Glucose Monitoring
    Policy CodePolicy 013
    Change TypeRevised
    Effective DateNov 10, 2016
    Last ReviewFeb 12, 2026
    Next Review DateNot specified
    Key ActionObtain authorization when CGM equipment or supplies are furnished by a non-contracted DME provider.
    SourceLink
    On This Page
    Initial CGM Approval CriteriaCovered CGM Codes and ThresholdsAuthorization, Documentation, and ReviewContinuous Glucose Monitoring ContextClinical Terms
    Related management practices
    Best practices also include proper diet and exercise, dietary and diabetic counseling, and monitoring
    Extreme glucose levels
    Symptom qualifierGlucose levels must be symptomatic
    Low thresholdBelow 50 mg/dL
    High thresholdAbove 300 mg/dL
  1. Age 8 years or older, based on assessed capability to be trained to use the device appropriately.
  2. Device approved for use by the FDA.
  3. Consultation with an endocrinologist or other diabetes specialist.
  4. Device ordered through a VCHCP-contracted DME vendor.
  5. Best practices documented: at least 3 finger-stick measurements daily, adherence to appropriate diet and exercise, and dietary and diabetic counseling and monitoring.
  6. Document at least one qualifying indication: extreme ('brittle') diabetes with recurrent glucose fluctuations, including symptomatic levels <50 mg/dL or >300 mg/dL; poorly controlled glucose with unexplained hypoglycemia or recurrent diabetic ketoacidosis refractory to multiple adjustments in compliant patients; frequent hospitalizations for poorly controlled diabetes; qualifying pregnancy or one-month postpartum circumstances; clinically significant hypoglycemia unawareness after appropriate adjustments and medical management; frequent nocturnal hypoglycemia despite appropriate insulin modifications and best practices; or legal blindness with poorly controlled glucose despite best practices requiring a special device.
  7. Documentation Required

    CGM and Insulin-Adjustment Documentation

    CGM is an adjunct to, not a replacement for, finger-stick measurements. Providers should document appropriate glucose identification and monitoring, and the patient must remain on the insulin dosage directed by the treating provider.

    • Cross-check CGM readings with a finger-stick measurement before making insulin adjustments whenever possible.
    • Document the finger-stick confirmation and the glucose values used to identify the patient's glucose level.
    • Document that insulin or other dosage adjustments were directed by the treating provider.
    • Best-practice monitoring includes 3 or more finger-stick measurements each day.
    Denial Risk

    Failure to Meet Medical-Necessity Criteria

    Coverage may be denied when the required medical-necessity criteria are not satisfied. The patient must meet every base criterion and have at least one documented qualifying clinical indication; failure of any required element places the request at denial risk.

    • Denial risk includes failure to document diabetes type, age and appropriate training capability, FDA approval, specialist consultation, required DME ordering, or adherence to best-practice monitoring and management.
    • Denial risk includes failure to establish a qualifying indication or failure to show that the indication persists despite the specified management, insulin modifications, or best practices.
    • The treating provider must direct the appropriate dosage, with CGM used adjunctively rather than as a substitute for finger-stick confirmation.
    Denial Risk

    No Qualifying Clinical Indication

    CGM coverage is at denial risk when none of the policy's qualifying clinical indications is demonstrated and documented, even if the patient's base criteria are otherwise met.

    • Qualifying indications include brittle diabetes with recurrent extreme glucose fluctuations; refractory poorly controlled diabetes with unexplained hypoglycemia or recurrent diabetic ketoacidosis; frequent hospitalizations for poorly controlled diabetes; qualifying pregnancy or one-month postpartum circumstances; clinically significant hypoglycemia unawareness after appropriate management; frequent nocturnal hypoglycemia despite appropriate insulin modifications and best practices; or legal blindness with poorly controlled glucose requiring a special device.
    The condition must persist after dietary, blood glucose, behavioral, and medical-management adjustments